Alnylam Files Trade Secret Misappropriation Suit Against Dicerna Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Dicerna Pharma (DRNA) Calls Alnylam (ALNY) Claims Poppycock
June 11, 2015 7:31 AM EDTDicerna Pharma (NASDAQ: DRNA) responded to a complaint filed yesterday by Alnylam Pharma (NASDAQ: ALNY) in the Superior Court of Middlesex County, Massachusetts. Dicerna believes the complaint is meritless and that Alnylam precipitously filed its lawsuit based on assumptions rather than facts.... More
Alnylam Pharma (ALNY) Sues Dicerna Pharma (DRNA) Over Trade Secret Misappropriation Allegations
June 10, 2015 4:01 PM EDTAlnylam Pharma (NASDAQ: ALNY) that it has filed a trade secret misappropriation lawsuit against Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) in the Superior Court of Middlesex County, Massachusetts. By this lawsuit, Alnylam seeks to stop misappropriation by Dicerna of the... More
